Learn About Scleroderma

What is the definition of Scleroderma?

Scleroderma is a disease that involves the buildup of scar-like tissue in the skin and elsewhere in the body. It also damages the cells that line the walls of small arteries.

Save information for later
Sign Up
What are the alternative names for Scleroderma?

Progressive systemic sclerosis; Systemic sclerosis; Limited scleroderma; CREST syndrome; Localized scleroderma; Morphea - linear; Raynaud's phenomenon - scleroderma

What are the causes of Scleroderma?

Scleroderma is a type of autoimmune disorder. In this condition, the immune system mistakenly attacks and damages healthy body tissue.

The cause of scleroderma is unknown. A buildup of a substance called collagen in the skin and other organs leads to the symptoms of the disease.

The disease most often affects people ages 30 to 50 years. Women get scleroderma more often than men. Some people with scleroderma have a history of being around silica dust and polyvinyl chloride, but most do not.

Widespread scleroderma can occur with other autoimmune diseases, including systemic lupus erythematosus and polymyositis. These cases are referred to as undifferentiated connective tissue disease or overlap syndrome.

What are the symptoms of Scleroderma?

Some types of scleroderma affect only the skin, while others affect the whole body.

  • Localized scleroderma, (also called morphea) -- Often affects only the skin on the chest, abdomen, or limb but not usually on the hands and face. Morphea develops slowly, and rarely spreads in the body or causes serious problems such as internal organ damage.
  • Systemic scleroderma, or sclerosis -- May affect large areas of skin and organs such as the heart, lungs, or kidneys. There are two main types, limited disease (CREST syndrome) and diffuse disease.

Skin signs of scleroderma may include:

  • Fingers or toes that turn blue or white in response to cold temperatures (Raynaud phenomenon)
  • Stiffness and tightness of skin of fingers, hands, forearm, and face
  • Hair loss
  • Skin that is darker or lighter than normal
  • Small white lumps of calcium beneath the skin that sometimes ooze a white substance that looks like toothpaste
  • Sores (ulcers) on the fingertips or toes
  • Tight and mask-like skin on the face
  • Telangiectasias, which are small, widened blood vessels visible beneath the surface on the face or at the edge of fingernails

Bone and muscle symptoms may include:

  • Joint pain, stiffness, and swelling, resulting in loss of motion. The hands are often involved due to fibrosis around tissue and tendons.
  • Numbness and pain in the feet.

Breathing problems may result from scarring in the lungs and can include:

  • Dry cough
  • Shortness of breath
  • Wheezing
  • Increased risk for lung cancer

Digestive tract problems may include:

  • Difficulty swallowing
  • Esophageal reflux or heartburn
  • Bloating after meals
  • Constipation
  • Diarrhea
  • Problems controlling stools

Heart problems may include:

  • Abnormal heart rhythm
  • Fluid around the heart
  • Fibrosis in heart muscle, decreasing heart function

Kidney and genitourinary problems may include:

  • Development of kidney failure
  • Erectile dysfunction in men
  • Vaginal dryness in women
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Scleroderma?

There is no specific treatment for scleroderma. Your provider will assess the extent of disease in the skin, lungs, kidneys, heart, and gastrointestinal tract.

People with diffuse skin disease (rather than limited skin involvement) may be more prone to progressive and internal organ disease. This form of the disease is classified as diffuse cutaneous systemic sclerosis (dcSSc). Body wide (systemic) treatments are most often used for this group of patients.

You will be prescribed medicines and other treatments to control your symptoms and prevent complications.

Medicines used to treat progressive scleroderma include:

  • Corticosteroids such as prednisone. However, doses above 10 mg per day are not recommended because higher doses may trigger kidney disease and high blood pressure.
  • Drugs that suppress the immune system such as mycophenolate, cyclophosphamide, cyclosporine or methotrexate.
  • Hydroxychloroquine to treat arthritis.

Some people with rapidly progressive scleroderma may be candidates for autologous hematopoietic stem cell transplantation (HSCT). This type of treatment needs to be performed in specialized centers.

Other treatments for specific symptoms may include:

  • Treatments to improve Raynaud phenomenon.
  • Medicines for heartburn or swallowing problems, such as omeprazole.
  • Blood pressure medicines, such as ACE inhibitors, for high blood pressure or kidney problems.
  • Light therapy to relieve skin thickening.
  • Medicines to improve lung function, such as bosentan and sildenafil.

Treatment often involves physical therapy as well.

Who are the top Scleroderma Local Doctors?
Highly rated in

The Journal Of Rheumatology


Christopher Denton is in Canada. Denton is rated as an Elite expert by MediFind in the treatment of Scleroderma. He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Scleroderma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Raynaud Phenomenon.

Highly rated in
Internal Medicine

Central Florida Health

The Villages - Santa Barbara Office

1580 Santa Barbara Blvd 
The Villages, FL 32162

Dinesh Khanna is a Rheumatologist and a Geriatrics doctor in The Villages, Florida. Dr. Khanna has been practicing medicine for over 38 years and is rated as an Elite doctor by MediFind in the treatment of Scleroderma. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Scleroderma, Hypertension, Arthritis, and Raynaud Phenomenon. He is licensed to treat patients in Florida. Dr. Khanna is currently accepting new patients.

Learn about our expert tiers
Learn more
Highly rated in

Stanford Health Care

Autoimmune Skin Disease Clinic

Redwood City, CA 94063

Lorinda Chung is a Rheumatologist in Redwood City, California. Dr. Chung has been practicing medicine for over 22 years and is rated as an Elite doctor by MediFind in the treatment of Scleroderma. She is also highly rated in 9 other conditions, according to our data. Her top areas of expertise are Scleroderma, Dermatomyositis, Polymyositis, and Scleroma. She is licensed to treat patients in California. Dr. Chung is currently accepting new patients.

What are the support groups for Scleroderma?

Some people can benefit from attending a support group for people with scleroderma.

What is the outlook (prognosis) for Scleroderma?

In some people, symptoms develop quickly for the first few years and continue to get worse. However, in most people, the disease gets worse slowly.

People who have only skin symptoms have a better outlook. Widespread (systemic) scleroderma can lead to.

  • Heart failure
  • Scarring of the lungs, called pulmonary fibrosis
  • High blood pressure in the lungs (pulmonary hypertension)
  • Kidney failure (scleroderma renal crisis)
  • Problems absorbing nutrients from food
  • Cancer
When should I contact a medical professional for Scleroderma?

Call your provider if you develop Raynaud phenomenon, progressive thickening of the skin, or trouble swallowing.

How do I prevent Scleroderma?

Raynaud's phenomenon
CREST syndrome
What are the latest Scleroderma Clinical Trials?
Is a History of Pre-eclampsia Before Systemic Sclerosis Onset a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigation of Upper Extremity Home Exercises Effects on Grip Strength, Range of Motion, Activity Performance and Funcionality in Patients With Scleroderma
What are the Latest Advances for Scleroderma?
Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis.
Rehabilitative interventions for ischaemic digital ulcers, pain, and hand functioning in systemic sclerosis: a prospective before-after study.
Tired of the same old research?
Check Latest Advances
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases.
Who are the sources who wrote this article ?

Published Date : May 31, 2020
Published By : Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Herrick AL, Pan X, Peytrignet S, et al. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017;76(7):1207-1218. PMID: 28188239  pubmed.ncbi.nlm.nih.gov/28188239/.

Poole JL, Dodge C. Scleroderma: therapy. In: Skirven TM, Osterman AL, Fedroczyk JM, Amadio PC, Feldscher SB, Shin EK, eds. Rehabilitation of the Hand and Upper Extremity. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 92.

Sullivan KM, Goldmuntz EA, Keyes-Elstein L, et al. Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med. 2018;378(1):35-47. PMID: 29298160 pubmed.ncbi.nlm.nih.gov/29298160/.

Varga J. Etiology and pathogenesis of systemic sclerosis. In: Firestein GS, Budd RC, Gabriel SE, Koretzky GA, McInnes IB, O'Dell JR, eds. Firestein and Kelly's Textbook of Rheumatology. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 88.

Varga J. Systemic sclerosis (scleroderma). In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 251.